Recall due to deviations from quality standards at the production site

Recall due to deviations from quality standards at the production site

Recall due to deviations from quality standards at the production site

Recall due to particles in the injection solution

Recall due to possible lack of sterility

Recall due to deviations from the specified values regarding resuspendability

Recall due to exceeding the active ingredient content

Recall due to delivery of an incorrect batch in Austria

Important information from the Federal Office for Safety in Health Care about the known risk of diabetic ketoacidosis (DKA) in cats with diabetes mellitus associated with the use of Senvelgo 15 mg/ml oral solution for cats (velagliflozin).

Recall due to non-compliant manufacture